Biovest to get IRS grant for BiovaxID development
Headquartered in Tampa, Florida, Biovest International, in collaboration with the National Cancer Institute, has developed a patient-specific, cancer vaccine, BiovaxID, with three clinical trials completed, including a Phase
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.